0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-08-01 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 09120540 2024-08-01 2025-07-31 09120540 2025-07-31 09120540 2024-07-31 09120540 2023-08-01 2024-07-31 09120540 2024-07-31 09120540 2023-07-31 09120540 bus:Director1 2024-08-01 2025-07-31 09120540 core:WithinOneYear 2025-07-31 09120540 core:WithinOneYear 2024-07-31 09120540 core:AfterOneYear 2025-07-31 09120540 core:AfterOneYear 2024-07-31 09120540 bus:Micro-entities 2024-08-01 2025-07-31 09120540 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 09120540 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 09120540 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 09120540 bus:FullAccounts 2024-08-01 2025-07-31
COMPANY REGISTRATION NUMBER: 09120540
Yash Pharma Limited
Filleted Unaudited Financial Statements
31 July 2025
Yash Pharma Limited
Balance Sheet
31 July 2025
2025
2024
£
£
Current assets
49,465
56,219
Creditors: amounts falling due within one year
9,898
13,183
--------
--------
Net current assets
39,567
43,036
--------
--------
Total assets less current liabilities
39,567
43,036
Creditors: amounts falling due after more than one year
16,757
18,083
--------
--------
22,810
24,953
--------
--------
Capital and reserves
22,810
24,953
--------
--------
Notes to the financial statements
1. Director's advances, credits and guarantees
During a previous year the company made a loan to the directors. The amount outstanding as at 31 July 2025 was £34,647 (31 July 2024 £45,439)
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 30 July 2026 , and are signed on behalf of the board by:
V Korwar
Director
Company registration number: 09120540
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 8 South Terrace, Alderley Edge, SK9 7HA.